Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Translational Development Acquisition Corp. (TDAC)

TDAC says ProLogium filed initial F-4 with SEC for pending merger

Neutral Impact 2 of 5 m&a Written later

Translational Development Acquisition Corp. (TDAC) said ProLogium Holding Inc. has filed a Form F-4 registration statement with the SEC, a step in the business combination announced on May 27, 2026. The filing is subject to SEC review and may be revised, and the release does not state a closing date or new deal terms.

Key points

  • ProLogium filed its initial Form F-4 with the SEC, as announced in a press release dated July 6, 2026.
  • The merger transaction was announced on May 27, 2026.
  • The filing is subject to SEC review and may be revised.
  • The forward-looking statements cite a $250 million Minimum Cash condition to closing.

The filing

CompanyTranslational Development Acquisition Corp. (TDAC)
Form8-K, current report
Filed with the SECJul 8, 2026, 8:05 AM ET
Accession number0001104659-26-081579

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.